Clinical Trial Update: A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 study evaluating an adjuvanted inactivated H7N9 influenza vaccine developed by Shanghai Institute Of Biological Pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H7n9 Influenza

Drugs mentioned

• Adjuvanted inactivated H7N9 influenza vaccine (adjuvanted inactivated H7N9 influenza vaccine)

Snippet

Sponsor: Shanghai Institute Of Biological Products | Conditions: H7N9 Influenza | Phase 2 | Status: COMPLETED